Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04651023
Status:
COMPLETED
Last Update Posted:
2020-12-03
First Post:
2020-11-16
Brief Title:
Shanghai Meiji Health Science and Technology Co Ltd
Sponsor:
Shanghai Meiji Health Science and Technology Co Ltd
Organization:
Shanghai Meiji Health Science and Technology Co Ltd
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity Ninety-five participants 23BMI30 kgm2 were randomly allocated to three groups a control group a 1 gday NnEx group and a 2 gday NnEx group The effects of the consumption of 2 gday or 1 gday NnEx for 12 weeks on indices of adiposity and fasting blood metabolic parameters were compared with those of no consumption of NnEx
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None